{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:40:04Z","timestamp":1776397204995,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["20240913"],"award-info":[{"award-number":["20240913"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10528-025-11150-y","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:49:43Z","timestamp":1749098983000},"page":"2508-2523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["POLR2H Serves as a Novel Prognostic Biomarker Correlated with Immune Infiltration in Prostate Cancer"],"prefix":"10.1007","volume":"64","author":[{"given":"Aiyun","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"18","key":"11150_CR1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1080\/15384101.2023.2265676","volume":"22","author":"N Bhandari","year":"2023","unstructured":"Bhandari N, Acharya D, Chatterjee A, Mandve L, Kumar P, Pratap S, Malakar P, Shukla SK (2023) Pan-cancer integrated bioinformatic analysis of RNA polymerase subunits reveal RNA Pol I member CD3EAP regulates cell growth by modulating autophagy. Cell Cycle 22(18):1986\u20132002","journal-title":"Cell Cycle"},{"issue":"3","key":"11150_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"11150_CR3","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/cells9071665","volume":"9","author":"A Carusillo","year":"2020","unstructured":"Carusillo A, Mussolino C (2020) DNA damage: from threat to treatment. Cells 9(7):1665","journal-title":"Cells"},{"key":"11150_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-3-031-11836-4_11","volume":"1390","author":"L Cato","year":"2022","unstructured":"Cato L, Shomali M (2022) AR structural variants and prostate cancer. Adv Exp Med Biol 1390:195\u2013211","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"11150_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11523-020-00720-2","volume":"15","author":"S Chowdhury","year":"2020","unstructured":"Chowdhury S, Bjartell A, Lumen N, Maroto P, Paiss T, Gomez-Veiga F, Birtle A, Kramer G, Kalinka E, Spa\u00ebth D, Feyerabend S, Matveev V, Lefresne F, Lukac M, Wapenaar R, Costa L (2020) Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer: the prostate cancer registry. Target Oncol 15(3):301\u2013315","journal-title":"Target Oncol"},{"issue":"7","key":"11150_CR6","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/j.1460-2075.1989.tb03605.x","volume":"8","author":"A Ciccodicola","year":"1989","unstructured":"Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG (1989) Molecular characterization of a gene of the \u2018EGF family\u2019 expressed in undifferentiated human NTERA2 teratocarcinoma cells. Embo J 8(7):1987\u20131991","journal-title":"Embo J"},{"issue":"4","key":"11150_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/1078-0432.CCR-21-1483","volume":"28","author":"TB Dorff","year":"2022","unstructured":"Dorff TB, Narayan V, Forman SJ, Zang PD, Fraietta JA, June CH, Haas NB, Priceman SJ (2022) Novel redirected T-cell immunotherapies for advanced prostate cancer. Clin Cancer Res 28(4):576\u2013584","journal-title":"Clin Cancer Res"},{"issue":"6","key":"11150_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-024-02979-8","volume":"30","author":"TB Dorff","year":"2024","unstructured":"Dorff TB, Blanchard MS, Adkins LN, Luebbert L, Leggett N, Shishido SN, Macias A, Del Real MM, Dhapola G, Egelston C, Murad JP, Rosa R, Paul J, Chaudhry A, Martirosyan H, Gerdts E, Wagner JR, Stiller T, Tilakawardane D, Pal S, Martinez C, Reiter RE, Budde LE, D\u2019Apuzzo M, Kuhn P, Pachter L, Forman SJ, Priceman SJ (2024) PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med 30(6):1636\u20131644","journal-title":"Nat Med"},{"issue":"5","key":"11150_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tibs.2018.02.010","volume":"43","author":"LH Gregersen","year":"2018","unstructured":"Gregersen LH, Svejstrup JQ (2018) The cellular response to transcription-blocking DNA damage. Trends Biochem Sci 43(5):327\u2013341","journal-title":"Trends Biochem Sci"},{"key":"11150_CR10","doi-asserted-by":"publisher","first-page":"8580043","DOI":"10.1155\/2022\/8580043","volume":"2022","author":"C Han","year":"2022","unstructured":"Han C, Deng Y, Xu W, Liu Z, Wang T, Wang S, Liu J, Liu X (2022) The roles of tumor-associated macrophages in prostate cancer. J Oncol 2022:8580043","journal-title":"J Oncol"},{"issue":"8","key":"11150_CR11","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.7150\/jca.69428","volume":"13","author":"MJ Ko","year":"2022","unstructured":"Ko MJ, Seo YR, Seo D, Park SY, Seo JH, Jeon EH, Kim SW, Park KU, Koo DB, Kim S, Bae JH, Song DK, Cho CH, Kim KS, Lee YH (2022) RPL17 promotes colorectal cancer proliferation and stemness through ERK and NEK2\/\u03b2-catenin signaling pathways. J Cancer 13(8):2570\u20132583","journal-title":"J Cancer"},{"issue":"12","key":"11150_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41580-019-0169-4","volume":"20","author":"H Lans","year":"2019","unstructured":"Lans H, Hoeijmakers JHJ, Vermeulen W, Marteijn JA (2019) The DNA damage response to transcription stress. Nat Rev Mol Cell Biol 20(12):766\u2013784","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"11150_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41416-020-01114-x","volume":"124","author":"R Lozano","year":"2021","unstructured":"Lozano R, Castro E, Arag\u00f3n IM, Cend\u00f3n Y, Cattrini C, L\u00f3pez-Casas PP, Olmos D (2021) Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer. Br J Cancer 124(3):552\u2013563","journal-title":"Br J Cancer"},{"key":"11150_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.fsi.2019.12.012","volume":"96","author":"ZZ Luo","year":"2020","unstructured":"Luo ZZ, Sun HM, Guo JW, Luo P, Hu CQ, Huang W, Shu H (2020) Molecular characterization of a RNA polymerase (RNAP) II (DNA directed) polypeptide H (POLR2H) in Pacific white shrimp (Litopenaeus vannamei) and its role in response to high-pH stress. Fish Shellfish Immunol 96:245\u2013253","journal-title":"Fish Shellfish Immunol"},{"issue":"3","key":"11150_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.eururo.2016.08.037","volume":"71","author":"J Mateo","year":"2017","unstructured":"Mateo J, Boysen G, Barbieri CE, Bryant HE, Castro E, Nelson PS, Olmos D, Pritchard CC, Rubin MA, de Bono JS (2017) DNA repair in prostate cancer: biology and clinical implications. Eur Urol 71(3):417\u2013425","journal-title":"Eur Urol"},{"issue":"3","key":"11150_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","volume":"81","author":"KN Maxwell","year":"2022","unstructured":"Maxwell KN, Cheng HH, Powers J, Gulati R, Ledet EM, Morrison C, Le A, Hausler R, Stopfer J, Hyman S, Kohlmann W, Naumer A, Vagher J, Greenberg SE, Naylor L, Laurino M, Konnick EQ, Shirts BH, AlDubayan SH, Van Allen EM, Nguyen B, Vijai J, Abida W, Carlo MI, Dubard-Gault M, Lee DJ, Maese LD, Mandelker D, Montgomery B, Morris MJ, Nicolosi P, Nussbaum RL, Schwartz LE, Stadler Z, Garber JE, Offit K, Schiffman JD, Nelson PS, Sartor O, Walsh MF, Pritchard CC (2022) Inherited TP53 variants and risk of prostate cancer. Eur Urol 81(3):243\u2013250","journal-title":"Eur Urol"},{"issue":"12","key":"11150_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G, Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA, Wyatt MR, Kalani Z, Chang JJ, Okamoto M, Stegmaier K, Golub TR, Boehm JS, Vazquez F, Root DE, Hahn WC, Tsherniak A (2017) Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet 49(12):1779\u20131784","journal-title":"Nat Genet"},{"issue":"4","key":"11150_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","volume":"28","author":"V Narayan","year":"2022","unstructured":"Narayan V, Barber-Rotenberg JS, Jung IY, Lacey SF, Rech AJ, Davis MM, Hwang WT, Lal P, Carpenter EL, Maude SL, Plesa G, Vapiwala N, Chew A, Moniak M, Sebro RA, Farwell MD, Marshall A, Gilmore J, Lledo L, Dengel K, Church SE, Hether TD, Xu J, Gohil M, Buckingham TH, Yee SS, Gonzalez VE, Kulikovskaya I, Chen F, Tian L, Tien K, Gladney W, Nobles CL, Raymond HE, Hexner EO, Siegel DL, Bushman FD, June CH, Fraietta JA, Haas NB (2022) PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med 28(4):724\u2013734","journal-title":"Nat Med"},{"issue":"2","key":"11150_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbcan.2018.09.001","volume":"1870","author":"S Park","year":"2018","unstructured":"Park S, Kim YS, Kim DY, So I, Jeon JH (2018) PI3K pathway in prostate cancer: all resistant roads lead to PI3K. Biochim Biophys Acta Rev Cancer 1870(2):198\u2013206","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"9","key":"11150_CR20","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1093\/nar\/gkz155","volume":"47","author":"T Paulsen","year":"2019","unstructured":"Paulsen T, Shibata Y, Kumar P, Dillon L, Dutta A (2019) Small extrachromosomal circular DNAs, microDNA, produce short regulatory RNAs that suppress gene expression independent of canonical promoters. Nucleic Acids Res 47(9):4586\u20134596","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"11150_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13215318","volume":"13","author":"AJ Petty","year":"2021","unstructured":"Petty AJ, Owen DH, Yang Y, Huang X (2021) Targeting tumor-associated macrophages in cancer immunotherapy. Cancers 13(21):1","journal-title":"Cancers"},{"issue":"5","key":"11150_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161(5):1215\u20131228","journal-title":"Cell"},{"issue":"5","key":"11150_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1751-1097.1993.tb09233.x","volume":"57","author":"A Sancar","year":"1993","unstructured":"Sancar A, Tang MS (1993) Nucleotide excision repair. Photochem Photobiol 57(5):905\u2013921","journal-title":"Photochem Photobiol"},{"issue":"10305","key":"11150_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG (2021) Prostate cancer. Lancet 398(10305):1075\u20131090","journal-title":"Lancet"},{"key":"11150_CR25","first-page":"339","volume":"14","author":"F Turco","year":"2022","unstructured":"Turco F, Gillessen S, Cathomas R, Buttigliero C, Vogl UM (2022) Treatment landscape for patients with castration-resistant prostate cancer: patient selection and unmet clinical needs. Res Rep Urol 14:339\u2013350","journal-title":"Res Rep Urol"},{"issue":"5","key":"11150_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3892\/ijo.2017.4138","volume":"51","author":"X Wang","year":"2017","unstructured":"Wang X, Tan C, Wang G, Cai JJ, Wang LP, Imperato-McGinley J, Zhu YS (2017) Dual action of NSC606985 on cell growth and apoptosis mediated through PKC\u03b4 in prostatic cancer cells. Int J Oncol 51(5):1601\u20131610","journal-title":"Int J Oncol"},{"issue":"11","key":"11150_CR27","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/cancers13112528","volume":"13","author":"TH Wang","year":"2021","unstructured":"Wang TH, Lee CY, Lee TY, Huang HD, Hsu JB, Chang TH (2021) Biomarker identification through multiomics data analysis of prostate cancer prognostication using a deep learning model and similarity network fusion. Cancers 13(11):2528","journal-title":"Cancers"},{"issue":"1","key":"11150_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cancers11010020","volume":"11","author":"CT Wu","year":"2018","unstructured":"Wu CT, Chen WC, Chen MF (2018) The response of prostate cancer to androgen deprivation and irradiation due to immune modulation. Cancers 11(1):20","journal-title":"Cancers"},{"issue":"14","key":"11150_CR29","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.2174\/1389201023666220413092507","volume":"23","author":"P Zhang","year":"2022","unstructured":"Zhang P, An Z, Sun C, Xu Y, Zhang Z (2022) FLG gene mutation up-regulates the abnormal tumor immune response and promotes the progression of prostate cancer. Curr Pharm Biotechnol 23(14):1658\u20131670","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"11150_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/ol.2024.14585","volume":"28","author":"B Zheng","year":"2024","unstructured":"Zheng B, Chen K, Liu X, Wan Z, Wu Y, Xu L, Xiao J, Chen J (2024) Transcription factor ETS1-mediated ECT2 expression promotes the malignant behavior of prostate cancer cells. Oncol Lett 28(4):453","journal-title":"Oncol Lett"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11150-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11150-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11150-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:40:36Z","timestamp":1776393636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11150-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11150"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11150-y","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was performed in accordance with the Declaration of Helsinki and approved by the human ethics committee of Shijiazhuang Hospital (Shijiazhuang, China) (identifier: 2024\/006). All patients signed informed consent forms and publish declarations before samples being collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}